<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

A BiTE-Sized Discussion on Next-Generation Preclinical Models

Bispecific T cell engagers (BiTE®) are a robust class of immuno-oncology (I/O) therapy which are engineered proteins that redirect T cells to destroy targeted tumor cells.